Catheter Precision earnings were -$11.7M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest VTAK earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$4.1M, down 2.4% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, VTAK reported annual earnings of -$71.4M, with 165.7% growth. The next VTAK earnings date is Mar 27, 2025.
What were Catheter Precision's earnings last quarter?
On VTAK's earnings call on Invalid Date, Catheter Precision (NYSEMKT: VTAK) reported Q3 2024 earnings per share (EPS) of -$2.01, up 28.98% year over year. Total VTAK earnings for the quarter were -$4.12 million. In the same quarter last year, Catheter Precision's earnings per share (EPS) was -$2.83.
The next VTAK earnings call is Invalid Date. Add VTAK to your watchlist to be reminded of Catheter Precision's next earnings date.
What was VTAK's earnings growth in the past year?
As of Catheter Precision's earnings date in Invalid Date, Catheter Precision's earnings has grown year over year. VTAK earnings in the past year totalled -$11.68 million.
Is Catheter Precision profitable or losing money?
As of the last Catheter Precision earnings report, Catheter Precision is currently losing money. Catheter Precision's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$11.68 million, a 85.03% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.